Cherry, L. (1993). Institute on alcohol, drugs, and disability: From grassroots activity to systems changes.
In A. W. Heinemann (Ed.), Substance abuse and physical disability (pp. 191-215). New York:
Haworth Press.
Chesher, N. J., Bousman, C. A., Gale, M., Norman, S. B., Twamley, E. W., Heaton, R. K., et al. (2011).
Chronic illness histories of adults entering treatment for co-occurring substance abuse and other
mental health disorders. American Journal on Addictions, 21(1), 1-4.
Chezem, L. (2005). Legal barriers to alcohol screening in emergency departments and trauma centers.
Alcohol Research & Health, 28(2), 73-77.
Chi, F. W., Campbell, C. I., Sterling, S., & Weisner, C. (2011). Twelve-step attendance trajectories over 7
years among adolescents entering substance use treatment in an integrated health plan. Addiction,
107 (5), 933-942.
Chi, K. R. (2011). Vaccines move forward against a range of addictions. Nature Medicine, 17(2), 146-
146.
Chick, J., Anton, R., Checinski, K., Croop, R., Drummond, D. C., Farmer, R., et al. (2000). A multicentre,
randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol
dependence or abuse. Alcohol & Alcoholism, 35(6), 587-593.
Chriqui, J. F., Terry-McElrath, Y., McBride, D. C., Eidson, S. S., & VanderWaal, C. J. (2007). Does state
certification or licensure influence outpatient substance abuse treatment program practices? Journal
of Behavioral Health Services & Research, 34(3), 309-328.
Chu, L. F., Liang, D. Y., Li, X., Sahbaie, P., D'arcy, N., Liao, G., et al. (2009). From mouse to man: The
5 -HT3 receptor modulates physical dependence on opioid narcotics. Pharmacogenetics & Genomics,
19 (3), 193-205.
Chun, J. S., Guydish, J., & Chan, Y. F. (2007). Smoking among adolescents in substance abuse treatment:
A study of programs, policy, and prevalence. Journal of Psychoactive Drugs, 39(4), 443-449.
Cinciripini, P. M., Cinciripini, L. G., Wallfisch, A., Haque, W., & Van, V. H. (1996). Behavior therapy
and the transdermal nicotine patch: Effects on cessation outcome, affect, and coping. Journal of
Consulting & Clinical Psychology, 64(2), 314-323.
Clark, D. B., Bukstein, O., & Cornelius, J. (2002). Alcohol use disorders in adolescents: Epidemiology,
diagnosis, psychosocial interventions, and pharmacological treatment. Paediatric Drugs, 4(8), 493-
502.
Clark, D. B., Wood, D. S., Martin, C. S., Cornelius, J. R., Lynch, K. G., & Shiffman, S. (2005).
Multidimensional assessment of nicotine dependence in adolescents. Drug & Alcohol Dependence,
77 (3), 235-242.
Clark, H. W. (2001). Residential substance abuse treatment for pregnant and postpartum women and their
children: Treatment and policy implications. Child Welfare, 80(2), 179-1.
Clark, H. W. (2011). A truly integrated treatment system must be both patient- and process-focused.
Addiction, 106(12), 2068-2069.
Clark, M. (2011). Conceptualising addiction: How useful is the construct? International Journal of
Humanities & Social Science, 1(13), 55-64.
Clark, R. E., Samnaliev, M., & McGovern, M. P. (2009). Impact of substance disorders on medical
expenditures for Medicaid beneficiaries with behavioral health disorders. Psychiatric Services, 60(1),
35-42.